| Patents for C12N 1 - Micro-organisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving micro-organisms or compositions thereof; Processes of preparing or isolating a composition containing a micro-organism; Culture media therefor (148,866) |
|---|
| 01/06/2005 | WO2004022698A3 Method for isolating and culturing unculturable microorganisms |
| 01/06/2005 | WO2003078631A9 Novel genes |
| 01/06/2005 | WO2003070925A9 Identification of 3-ketosteroid 9-alfa-hydroxylase genes and microorganisms blocked in 3-ketosteroid 9-alfa-hydroxylase activity |
| 01/06/2005 | WO2003020890A3 Genes encoding baeyer-villiger monooxygenases |
| 01/06/2005 | WO2002055700A8 Human genes and gene expression products isolated from human prostate |
| 01/06/2005 | US20050005329 Isolated nucleotide sequence encoding polypeptide derived from algae Isochrysis galbana; expression of vector results in production of polyunsaturated fatty acid; use in pharmaceutical compositions, animal feeds and cosmetics |
| 01/06/2005 | US20050005328 Nucleotide sequence encoding a polypeptide derived from fungus Thraustochytrium aureum; expression of vector results in production of polyunsaturated fatty acid (omega 6-docosapentaenoic acid and docosahexaenoic acid); use in pharmaceutical compositions, animal feeds and cosmetics |
| 01/06/2005 | US20050004355 Diagnosing immune system disorders using defensin specific immuoglobulin; microbiocides and treatment of respiratory system disorders |
| 01/06/2005 | US20050004352 Single-chain multiple antigen-binding molecule, its preparation and use |
| 01/06/2005 | US20050004351 Therapeutic and diagnostic domain 1 beta2GP1 polypeptides and methods of using same |
| 01/06/2005 | US20050004034 Human C-Maf compositions and methods of use therefor |
| 01/06/2005 | US20050004021 Enzyme inhibitor for therapy of thrombosis, blood disorders |
| 01/06/2005 | US20050003986 Mutants in subtilisin gene; detergents; oxidation resistance |
| 01/06/2005 | US20050003985 From Bacillus; hybrid protein; detergents, cleaning compounds |
| 01/06/2005 | US20050003539 Plasmid maintenance system for antigen delivery |
| 01/06/2005 | US20050003514 Chlamydospores and process for producing the same |
| 01/06/2005 | US20050003513 Treating with mutagen (ultraviolet radiation or 1-methyl-3-nitro-1-nitroso-guanidine) then culturing |
| 01/06/2005 | US20050003512 Attenuated pasteurella for use as tool in developing bactericidal agents; immunotherapy |
| 01/06/2005 | US20050003511 Expression vector comprising pi replicon and f factor orgin of replication gene sequences for use as tools in selective cloning and/or manipulation of large regions of DNA; heterologous gene transfer and expression |
| 01/06/2005 | US20050003510 Transgenic lactobacillus which has been modified to express heterologous gene products on cell wall surface for use as therapeutic tool in prevention of bacterial infection and inflammatory response |
| 01/06/2005 | US20050003509 Using chaperone protein activity to identify modulators for treatment and prevention of fungal growth; fungicides |
| 01/06/2005 | US20050003504 Alkaline protease from Bacillus gibsonii (DSM 14391) and washing and cleaning products comprising said alkaline protease |
| 01/06/2005 | US20050003500 Producing optically active vicinal diols via reacting (2S,3S)-2,3-butanediol dehydrogenase, microorganism, 2,3-butanedione and (2S,3S)-2,3-butanediol in presence of reduced nicotinamide adenine dinucleotides; for use as raw material in flavors and pharmeceuticals |
| 01/06/2005 | US20050003497 Method for producing cadaverine dicarboxylate |
| 01/06/2005 | US20050003495 Method for producing L-lysine or L-arginine by using methanol-assimilating bacterium |
| 01/06/2005 | US20050003494 Mutated gene from corynebacterium glutamicum |
| 01/06/2005 | US20050003492 Novel polypeptide |
| 01/06/2005 | US20050003489 Conformational and topological protein regulation |
| 01/06/2005 | US20050003487 Chordin dorsalizing and hemoglobin inducing polypeptides and nucleic acids encoding the same |
| 01/06/2005 | US20050003485 Method for recombinant production of polypeptides |
| 01/06/2005 | US20050003476 Nove glycosyltransferase genes |
| 01/06/2005 | US20050003474 Carotenoid biosynthesis |
| 01/06/2005 | US20050003473 Aspergillus ochraceus 11 alpha hydroxylase and oxidoreductase |
| 01/06/2005 | US20050003454 Conformational and topological protein regulation |
| 01/06/2005 | US20050003453 G-CSF analog compositions and methods |
| 01/06/2005 | US20050003451 Immunoglobulin for use in diagnosis, prevention and treatment of infection, autoimmune, inflammatory and cell proliferative diseases; immunotherapy |
| 01/06/2005 | US20050003446 Peptide sequences for use in identification of modulators for use in treatment and prevention of inflammatory, cell proliferative, arteriosclerotic and skin disorders |
| 01/06/2005 | US20050003442 Delta4-desaturase genes and uses thereof |
| 01/06/2005 | US20050003439 Mutations in the KCNE1 gene encoding human minK which cause arrhythmia susceptibility thereby establishing KCNE1 as an LQT gene |
| 01/06/2005 | US20050003438 Conformational and topological protein regulation |
| 01/06/2005 | US20050003436 Release of intracellular material |
| 01/06/2005 | US20050003423 Expression vector comprising polynucleotide sequences coding transcriptional regulator associated with lysine biosynthesis for use in generation of transgenic bacterial cells with enhanced lysine biosynthesis; for enhancing animal feeds, cosmetics and medicines |
| 01/06/2005 | US20050003419 Enhanced enzymatic polypeptide for use as component of cleaning compound; detergents; papermaking; textiles |
| 01/06/2005 | US20050003412 Protein activator of superoxide production for use in treatment and prevention of cancer, psoriasis, prostatic hypertrophy, benign prostatic hypertrophy and cardiovascular disease |
| 01/06/2005 | US20050003409 Expression vector comprising nucleotide sequences coding polyketide synthase for use in transformation, and propagation of streptomyces cells capable of producing moxidectin; bactericides; nematocide |
| 01/06/2005 | US20050003401 Expression vector comprising nucleotide sequences coding archaeal replication factor A (RFA) for use in generating polypeptide which enhances stability and efficacy of gene amplification products |
| 01/06/2005 | US20050003400 Using osteoprotegrin binding agent as tool in identifying modulator for treatment and prevention of osteoporosis and bone disorders |
| 01/06/2005 | US20050003391 Bioassay for detection of receptor activated nuclear factor kappa beta ligand (RANKL); identifying modulator immune and inflammatory response |
| 01/06/2005 | US20050003383 Linoleate isomerase |
| 01/06/2005 | US20050003382 Streptomyces culture for use in the digestion of degradation resistant protein in waste water, organic waste liquids and industrial wastes; bioremediation |
| 01/06/2005 | US20050003370 Expression vector comprising nucleotide sequences coding membrane receptor proteins for use in identifying modulators for treatment and prevention of cell proliferative, nervous system, reproductive cardiovascular and inflammation disorders |
| 01/06/2005 | US20050003353 Production of adenine nucleotide translocator (ant), novel ant ligands and screening assays therefor |
| 01/06/2005 | US20050003352 Comprises recombinant mitochondrial transport protein for diagnosis, prevention and treatment of alzheimer's, diabetes, parkinson's, huntington's, cancers |
| 01/06/2005 | US20050002965 Recombinant adenovirus with enhanced therapeutic effect and pharmaceutical composition comprising said recombinant adenovirus |
| 01/06/2005 | US20050002964 Adhesion inhibition of fungi |
| 01/06/2005 | US20050002950 Vaccine preventing infection |
| 01/06/2005 | US20050002944 Chlamydia antigens and corresponding DNA fragments and uses thereof |
| 01/06/2005 | US20050002938 To screen for inhibitors of cell growth and to develop small molecule therapeutics for treating cancers |
| 01/06/2005 | US20050002937 Anti-IL-12 antibodies, compositions, methods and uses |
| 01/06/2005 | US20050002874 Selection and use of lactic acid bacteria for reducing dental caries and bacteria causing dental caries |
| 01/06/2005 | CA2771875A1 Variant humicola grisea cbh1.1 |
| 01/06/2005 | CA2522867A1 Genes encoding carotenoid compounds |
| 01/05/2005 | EP1493817A1 Resistance against plant pests |
| 01/05/2005 | EP1493814A1 Cell-free synthesis of polyketides |
| 01/05/2005 | EP1493812A2 A truncated keratinocyte growth factor (KGF) having increased biological activity |
| 01/05/2005 | EP1493811A1 Novel promoters |
| 01/05/2005 | EP1493809A1 Recombinant dna having hydantoinase gene and carbamylase gene and process for producing amino acid |
| 01/05/2005 | EP1493807A1 A Streptomyces strain with a protease capable of decomposing proteins recalcitrant to proteolysis |
| 01/05/2005 | EP1493806A1 Use of compounds involved in biosynthesis of nucleic acids as cryoprotective agents |
| 01/05/2005 | EP1493432A1 In vivo method of obtaining cell components |
| 01/05/2005 | EP1493028A2 Phage displayed pdz domain ligands |
| 01/05/2005 | EP1492880A1 Ex vivo method for determination of cetp activity and efficacy of heart disease treatment |
| 01/05/2005 | EP1492877A2 Improved method for the production of vitamin b12 |
| 01/05/2005 | EP1492874A1 Multigenic vector plasmids and methods for increasing expression of recombinant polypeptides |
| 01/05/2005 | EP1492867A2 Identification of virulence associated regions rd1 and rd5 enabling the development of imrpoved vaccines of m. bovis bcg and m. microti |
| 01/05/2005 | EP1492817A2 Therapeutic monoclonal anti-tirc7 antibodies for use in immune related and other diseases |
| 01/05/2005 | EP1492811A1 Muteins of the c5a anaphylatoxin, nucleic acid molecules encoding such muteins, and pharmaceutical uses of muteins of the c5a anaphylatoxin |
| 01/05/2005 | EP1492806A2 Human smooth muscle myosin heavy chain |
| 01/05/2005 | EP1492559A2 Truncated 24 kda basic fibroblast growth factor |
| 01/05/2005 | EP1492549A1 Compositions and methods for augmenting kidney function |
| 01/05/2005 | EP1492476A1 Device for mixing and/or injecting cements |
| 01/05/2005 | EP1492409A2 Peptides with anti-hypertensive properties |
| 01/05/2005 | EP1492404A2 Novel spinosyn-producing polyketide synthases |
| 01/05/2005 | EP1204608B1 Method of purifying water, suitable bacteria for the method and use thereof |
| 01/05/2005 | DE19957065B4 Screening-Verfahren für Arzneistoffe A screening method for drugs |
| 01/05/2005 | DE10326187A1 Zellen als Träger für Bakterien Cells as carriers for bacteria |
| 01/05/2005 | DE10325404A1 Hygienische Sicherung der Mehrkammerdosiersprühtechnik und deren probiotische Anwendung zur Applikation lebensfähiger Mikroorganismen Hygienic securing Mehrkammerdosiersprühtechnik and their probiotic application to application of viable microorganisms |
| 01/05/2005 | DE10325026A1 Bakterien mit erhöhter Proteinsekretion, Nukleotidsequenzen codierend für ein SecA Protein mit erhöhter Proteinsekretion sowie Verfahren zur Produktion von Proteinen Bacteria with increased protein secretion, nucleotide sequences coding for a protein with increased SecA protein secretion as well as methods for producing proteins |
| 01/05/2005 | CN1561391A Recombinant bacterial phytases and uses thereof |
| 01/05/2005 | CN1561387A Probiotic bifidobacterium strains |
| 01/05/2005 | CN1561386A Method of fermentation |
| 01/05/2005 | CN1561343A Soluble T cell receptor |
| 01/05/2005 | CN1561229A Virus coat protein/receptor chimeras and methods of use |
| 01/05/2005 | CN1560257A Expression carrier of laccase, microorganism strain of expression, laccase protein of expression and application thereof |
| 01/05/2005 | CN1560254A Gene of L-lactate dehydrogenase, recombined carrier containing said gene and host-cell thereof |
| 01/05/2005 | CN1560253A Preparation of antibiotic hPAB with multicopy tandem peptide |
| 01/05/2005 | CN1560249A Fibroblast growth factor-19 (FGF-19) nucleic acids and polypeptides and methods of use for the treatment of obesity |
| 01/05/2005 | CN1560246A Biologic passive collecting process and collecting apparatus thereof |
| 01/05/2005 | CN1560245A Enzyme detoxicant and preparation process and application thereof |
| 01/05/2005 | CN1560242A Mutant alpha-amylase |